191 related articles for article (PubMed ID: 27285989)
1. Protein inhibitor of activated STAT 4 (PIAS4) regulates pro-inflammatory transcription in hepatocytes by repressing SIRT1.
Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Fang M; Xia J; Xu Y
Oncotarget; 2016 Jul; 7(28):42892-42903. PubMed ID: 27285989
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Shao J; Bian Y; Fang M; Xu Y
Sci Rep; 2016 Jun; 6():28432. PubMed ID: 27323886
[TBL] [Abstract][Full Text] [Related]
3. The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice.
Fan Z; Li L; Li M; Zhang X; Hao C; Yu L; Zeng S; Xu H; Fang M; Shen A; Jenuwein T; Xu Y
Hepatology; 2017 Jun; 65(6):1904-1919. PubMed ID: 28244120
[TBL] [Abstract][Full Text] [Related]
4. Cysteine cathepsins control hepatic NF-κB-dependent inflammation via sirtuin-1 regulation.
de Mingo Á; de Gregorio E; Moles A; Tarrats N; Tutusaus A; Colell A; Fernandez-Checa JC; Morales A; Marí M
Cell Death Dis; 2016 Nov; 7(11):e2464. PubMed ID: 27831566
[TBL] [Abstract][Full Text] [Related]
5. Protein inhibitor of activated STAT 4 (PIAS4) regulates liver fibrosis through modulating SMAD3 activity.
Xu H; Fan Z; Tian W; Xu Y
J Biomed Res; 2016 Nov; 30(6):496-501. PubMed ID: 27924068
[TBL] [Abstract][Full Text] [Related]
6. PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells.
Sun L; Li H; Chen J; Iwasaki Y; Kubota T; Matsuoka M; Shen A; Chen Q; Xu Y
J Cell Sci; 2013 Sep; 126(Pt 17):3939-47. PubMed ID: 23843607
[TBL] [Abstract][Full Text] [Related]
7. Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-
Yang XD; Chen Z; Ye L; Chen J; Yang YY
Pharm Biol; 2021 Dec; 59(1):922-932. PubMed ID: 34243681
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of Sirt1 in mouse livers protects against endotoxemic liver injury by acetylating and activating NF-κB.
Cui X; Chen Q; Dong Z; Xu L; Lu T; Li D; Zhang J; Zhang M; Xia Q
Cell Death Dis; 2016 Oct; 7(10):e2403. PubMed ID: 27711079
[TBL] [Abstract][Full Text] [Related]
9. Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis.
Song CY; Zeng X; Wang Y; Shi J; Qian H; Zhang Y; Fang JQ; Sheng X; Zheng JM; Chen YX
J Gastroenterol Hepatol; 2015 Feb; 30(2):405-12. PubMed ID: 25089018
[TBL] [Abstract][Full Text] [Related]
10. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.
Huang Q; Wang T; Yang L; Wang HY
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534819
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
Zeng W; Shan W; Gao L; Gao D; Hu Y; Wang G; Zhang N; Li Z; Tian X; Xu W; Peng J; Ma X; Yao J
Sci Rep; 2015 Nov; 5():16013. PubMed ID: 26525891
[TBL] [Abstract][Full Text] [Related]
14. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
Yin H; Hu M; Liang X; Ajmo JM; Li X; Bataller R; Odena G; Stevens SM; You M
Gastroenterology; 2014 Mar; 146(3):801-11. PubMed ID: 24262277
[TBL] [Abstract][Full Text] [Related]
15. Sirtuin 1 activation alleviates primary biliary cholangitis via the blocking of the NF-κB signaling pathway.
Li Y; Xi Y; Tao G; Xu G; Yang Z; Fu X; Liang Y; Qian J; Cui Y; Jiang T
Int Immunopharmacol; 2020 Jun; 83():106386. PubMed ID: 32193100
[TBL] [Abstract][Full Text] [Related]
16. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
[TBL] [Abstract][Full Text] [Related]
17. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
18. Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice.
Tian W; Xu H; Fang F; Chen Q; Xu Y; Shen A
Hepatology; 2013 Aug; 58(2):576-88. PubMed ID: 23281043
[TBL] [Abstract][Full Text] [Related]
19. Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells.
Borji M; Nourbakhsh M; Shafiee SM; Owji AA; Abdolvahabi Z; Hesari Z; Ilbeigi D; Seiri P; Yousefi Z
Biochem Genet; 2019 Aug; 57(4):507-521. PubMed ID: 30697640
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver.
Tian Y; Ma J; Wang W; Zhang L; Xu J; Wang K; Li D
Mol Cell Biochem; 2016 Nov; 422(1-2):75-84. PubMed ID: 27613163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
